Flu experiment shows no transmission in shared hotel room

In a unique study, influenza-infected college students shared a hotel room with healthy middle-aged volunteers for two weeks, yet no infections occurred. Researchers attribute this to limited coughing, good ventilation, and participants' age. The findings underscore the role of airflow and masks in preventing flu spread.

Researchers from the University of Maryland conducted an experiment in a quarantined Baltimore-area hotel floor, placing five college students with confirmed influenza alongside 11 healthy middle-aged adults. Over two weeks in 2023 and 2024, participants engaged in daily interactions like conversations, yoga, stretching, dancing, and sharing items such as pens, tablets, and microphones. Despite close contact, none of the healthy volunteers became infected, as confirmed by daily nasal swabs, saliva, blood samples, and air monitoring using the Gesundheit II machine.

The study, published January 7, 2026, in PLOS Pathogens, is the first controlled trial examining airborne flu transmission from naturally infected individuals. "At this time of year, it seems like everyone is catching the flu virus. And yet our study showed no transmission -- what does this say about how flu spreads and how to stop outbreaks?" said Dr. Donald Milton, a professor at the university's School of Public Health and an expert in infectious disease aerobiology.

Key factors included the infected students' high nasal virus levels but rare coughing, releasing only small amounts of virus. Dr. Jianyu Lai, who led the data analysis, noted, "Our data suggests key things that increase the likelihood of flu transmission -- coughing is a major one." Ventilation from a heater and dehumidifier rapidly mixed and diluted the air, reducing virus concentration. Middle-aged adults' lower susceptibility to flu also likely contributed, according to Lai.

Milton emphasized airborne transmission's role in flu spread and called for evidence-based infection controls. He advised using portable air purifiers to stir and clean air, and N95 masks during close, indoor encounters with coughers. The research highlights ongoing needs amid seasonal flu's global toll: up to 1 billion infections yearly, with the current U.S. season reporting 7.5 million cases, 81,000 hospitalizations, and over 3,000 deaths.

The team, including collaborators from institutions like Icahn School of Medicine at Mount Sinai and the University of Hong Kong, received funding from sources such as the NIAID and the Balvi Filantropic Fund.

관련 기사

UBC Okanagan engineers' airflow device capturing exhaled aerosols in a simulated indoor space, outperforming traditional ventilation.
AI에 의해 생성된 이미지

UBC Okanagan engineers develop airflow device to capture indoor airborne pathogens

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Engineers at the University of British Columbia’s Okanagan campus have designed a new airflow device that traps exhaled aerosols almost immediately, sharply reducing exposure to airborne pathogens in simulations. Early results suggest the system can substantially outperform conventional ventilation approaches in shared indoor spaces.

An international team led by ETH Zurich and including researchers in Japan has used a new high‑resolution imaging technique to watch, live, as influenza viruses penetrate human cells. The work shows that cells actively engage with the virus, helping to draw it inside in a process that resembles surfing along the cell membrane, and could inform the development of targeted antiviral therapies.

AI에 의해 보고됨

Scientists have discovered that the body's rapid response in nasal cells largely determines whether a rhinovirus infection leads to a mild cold or more severe symptoms. Using lab-grown human nasal tissue, researchers showed how interferons coordinate defenses to contain the virus early. The findings, published January 19 in Cell Press Blue, emphasize the role of host responses over viral traits alone.

Scientists have estimated how quickly certain E. coli strains spread between people and found one lineage with a basic reproduction number comparable to H1N1 swine flu. Drawing on genomic data from the UK and Norway, the analysis—published November 4, 2025, in Nature Communications—models transmission for three ST131 clades and underscores implications for tracking antibiotic-resistant infections.

AI에 의해 보고됨

New research challenges long-standing concerns about the antiviral drug oseltamivir, known as Tamiflu, and its potential link to serious neuropsychiatric events in children. Instead, the study attributes such symptoms to the influenza virus itself and shows that Tamiflu treatment halves the risk of these complications. The findings, based on a large analysis of pediatric health records, aim to reassure families and doctors about the drug's safety.

Belgian researchers working with Danish partners report that respiratory syncytial virus (RSV) infections in early infancy are linked to a higher risk of childhood asthma, especially in children with a genetic tendency to allergies. In experimental models, protecting newborns from RSV prevented the immune changes associated with later asthma. The findings, published in Science Immunology, highlight potential long-term benefits of emerging RSV prevention tools.

AI에 의해 보고됨 사실 확인됨

A team of microbiologists suggests that infections occurring alongside SARS-CoV-2 may contribute to some cases of long COVID, potentially by reactivating latent pathogens such as Epstein–Barr virus or altering the course of tuberculosis. Their perspective, published in eLife, stresses that this remains a hypothesis and calls for large studies and better animal models to test whether these co-infections help drive persistent symptoms like fatigue and brain fog.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부